(Q38452688)

3 September 2017

1 reference

title

Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out? (English)

1 reference

3 September 2017

1 reference

Nicholas K Mollanazar

series ordinal

1

1 reference

3 September 2017

Peter K Smith

series ordinal

2

1 reference

3 September 2017

Gil Yosipovitch

series ordinal

3

1 reference

3 September 2017

1 May 2015

1 reference

Clinical Reviews in Allergy & Immunology

3 September 2017

1 reference

3 September 2017

51

1 reference

3 September 2017

3

1 reference

3 September 2017

263-292

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-015-8488-5

3 September 2017

0 references

cites work

Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in large-scale studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Atopic dermatitis: beyond the itch that rashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Clinical characteristics of pruritus in chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

What causes itch in atopic dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Itch mechanisms and circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The epidermal nerve fibre network: characterization of nerve fibres in human skin by confocal microscopy and assessment of racial variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Skin and hair follicle innervation in experimental models: a guide for the exact and reproducible evaluation of neuronal plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Comparison of responses of primate spinothalamic tract neurons to pruritic and algogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Anterolateral cordotomy: results, complications and causes of failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Touch and surgical division of the anterior quadrant of the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

21 January 2018

Basic mechanisms of itch

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Butorphanol suppression of histamine itch is mediated by nucleus accumbens and septal nuclei: a pharmacological fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Separate peripheral pathways for pruritus in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Role of Topical Emollients and Moisturizers in the Treatment of Dry Skin Barrier Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Effect of moisturizers on epidermal barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Epidermal hyperproliferation and decreased skin barrier function in mice overexpressing stratum corneum chymotryptic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cutaneous or respiratory exposures to peanut allergens in mice and their impacts on subsequent oral exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The pruritus receptor unit: a target for novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Peripheral mechanisms of itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Proenkephalin A gene products activate a new family of sensory neuron--specific GPCRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

BAM8-22 peptide produces itch and nociceptive sensations in humans independent of histamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A subpopulation of nociceptors specifically linked to itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The neuroscience of Helmholtz and the theories of Johannes Müller. Part 2: Sensation and perception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Proteinase-activated receptors: novel signals for peripheral nerves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cathepsin S elicits itch and signals via protease-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Signal transduction by protease-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

TRP channel proteins and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Transient receptor potential channels as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Transient receptor potential channels and dermatological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The vanilloid receptor: a molecular gateway to the pain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Neurovascular aspects of skin neurogenic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Transient receptor potential vanilloid (TRPV-1) promotes neurogenic inflammation in the pancreas via activation of the neurokinin-1 receptor (NK-1R).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

TRPA1 modulates mechanotransduction in cutaneous sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

21 January 2018

TRP channels in the skin

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The ion channel TRPA1 is required for chronic itch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Topical application of TRPA1 agonists and brief cold exposure accelerate skin permeability barrier recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Scraping through the ice: uncovering the role of TRPM8 in cold transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Roles of transient receptor potential proteins (TRPs) in epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Menthol: a refreshing look at this ancient compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Successful treatment of therapy-resistant pruritus in lichen amyloidosis with menthol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A role for nociceptive, myelinated nerve fibers in itch sensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

21 January 2018

The neurobiology of itch

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Intraepidermal nerve fibers increase in dry skin of acetone-treated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Trk receptors: roles in neuronal signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

NGF sensitizes nociceptors for cowhage- but not histamine-induced itch in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Atopic dermatitis and cytokines: recent patents in immunoregulatory and therapeutic implications of cytokines in atopic dermatitis--part I: cytokines in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The biology of thymic stromal lymphopoietin (TSLP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Thymic stromal lymphopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Asthma and allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Atopic dermatitis and the atopic march

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Netherton syndrome: skin inflammation and allergy by loss of protease inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

IL-31: a new link between T cells and pruritus in atopic skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

IL-31 regulates differentiation and filaggrin expression in human organotypic skin models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cytokines as therapeutic targets in skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

New insights into atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Eosinophils and atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Th2 Cytokines and Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The cytokine interleukin-33 mediates anaphylactic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Increased serum levels of interleukin 33 in patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Notch signaling and the developing skin epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The molecular basis of Notch signaling: a brief overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Notch signaling: cell fate control and signal integration in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

New insights into atopic dermatitis: role of skin barrier and immune dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The potential role of impaired Notch signalling in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Thymic stromal lymphopoietin: master switch for allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Sensing the outside world: TSLP regulates barrier immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The role of thymic stromal lymphopoietin (TSLP) in allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Histamine and H1-antihistamines: celebrating a century of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Phospholipase Cbeta 3 mediates the scratching response activated by the histamine H1 receptor on C-fiber nociceptive neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Flare and Itch Induced by Substance P in Human Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Vascular responses of human skin to injection of substance P and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Neuromediators--a crucial component of the skin immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Modern aspects of cutaneous neurogenic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

TRP channels as novel players in the pathogenesis and therapy of itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Neuropeptides activate human mast cell degranulation and chemokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Aprepitant as an antipruritic agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Aprepitant against pruritus in patients with solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Aprepitant for erlotinib-induced pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Histamine enhances the production of nerve growth factor in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP-GRPR signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cellular basis of itch sensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The cells and circuitry for itch responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Role of spinal bombesin-responsive neurons in nonhistaminergic itch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Overexpression of the gastrin-releasing peptide in cutaneous nerve fibers and its receptor in the spinal cord in primates with chronic itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Itch-associated peptides: RNA-Seq and bioinformatic analysis of natriuretic precursor peptide B and gastrin releasing peptide in dorsal root and trigeminal ganglia, and the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Itch: scratching more than the surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The acetylcholine-induced flare response in evaluation of small fiber dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Recent studies of cutaneous nociception in atopic and non-atopic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Glucocorticoid activation of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene: involvement of transcription factor Egr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

In vivo release of non-neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Extraneuronal cholinergic system in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The role of nicotinic receptors in B-lymphocyte development and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The cholinergic anti-inflammatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cannabinoid system in the skin - a possible target for future therapies in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Attenuation of allergic contact dermatitis through the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Psychodermatology: a guide to understanding common psychocutaneous disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Relationship between itch and psychological status of patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Association of stress with symptoms of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Autonomic, Neuroendocrine, and Immune Responses to Psychological Stress: The Reactivity Hypothesisa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Stress-induced immune dysfunction: implications for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The skin as a mirror of the soul: exploring the possible roles of serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Glucocorticoids and the Th1/Th2 balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Mast cells: the Jekyll and Hyde of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Atopic dermatitis and stress? How do emotions come into skin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The critical role of mast cells in allergy and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Topical therapies for pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Oatmeal in dermatology: a brief review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Ceramide and cholesterol composition of the skin of patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Epidermal barrier dysfunction in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Moisturization and skin barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The concept of the acid mantle of the skin: its relevance for the choice of skin cleansers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Skin pH: from basic science to basic skin care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Management of patients with atopic dermatitis: the role of emollient therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cholinergic induction of perspiration attenuates nonhistaminergic pruritus in the skin of patients with atopic dermatitis and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Guidelines for management of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Consensus conference on pediatric atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Atopic dermatitis: broadening the perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The effects of treatment on itch in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Relieving the pruritus of atopic dermatitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Treatment of pruritic diseases with topical calcineurin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The immunosuppressant FK506 activates capsaicin- and bradykinin-sensitive DRG neurons and cutaneous C-fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Low systemic exposure in infants with atopic dermatitis in a 1-year pharmacokinetic study with pimecrolimus cream 1%*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Safety and efficacy of tacrolimus ointment 0.1% (Protopic) in atopic dermatitis: a Canadian open-label multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Treatment of prurigo nodularis with topical capsaicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The capsaicin receptor: a heat-activated ion channel in the pain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cellular and Molecular Mechanisms of Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Neuropharmacological mechanisms of capsaicin and related substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Management of itch in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Topical capsaicin. The fire of a 'hot' medicine is reignited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Effect of topical pramoxine on experimentally induced pruritus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Relief of experimentally induced pruritus with a novel eutectic mixture of local anaesthetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Central neuropathic itch: a new treatment option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Treatment of refractory atopic dermatitis using 'wet-wrap' dressings and diluted corticosteroids: results of standardized treatment in both children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Topical steroids under wet-wrap dressings in atopic dermatitis--a vehicle-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Novel sodium hypochlorite cleanser shows clinical response and excellent acceptability in the treatment of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The role of antiseptic agents in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Strontium is a potent and selective inhibitor of sensory irritation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Strontium nitrate suppresses chemically-induced sensory irritation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Strontium nitrate decreased histamine-induced itch magnitude and duration in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A novel topical formulation containing strontium chloride significantly reduces the intensity and duration of cowhage-induced itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Receptors for acylethanolamides-GPR55 and GPR119

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Ultraviolet phototherapy for pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Treatment of atopic dermatitis with the xenon chloride excimer laser.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A randomized trial of methotrexate versus azathioprine for severe atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Atopic dermatitis in African American children: addressing unmet needs of a common disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

21 January 2018

Mirtazapine for pruritus

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Neurophysiological and neurochemical basis of modern pruritus treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Butorphanol for treatment of intractable pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

mu-Opposing actions of the kappa-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Efficacy of systemic treatments for atopic dermatitis in racial and ethnic minorities in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Preventive effect of acupuncture on histamine-induced itch: a blinded, randomized, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Electrical ear acupuncture reduces histamine-induced itch (alloknesis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema - a blinded, randomized, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The brain circuitry mediating antipruritic effects of acupuncture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

A meta-analysis of the effectiveness of psychological interventions for adults with skin conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Habit-reversal: A method of eliminating nervous habits and tics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The behavioral treatment of neurodermatitis through habit-reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Habit reversal: a turning point in the treatment of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Adherence in dermatology: a review of the last 20 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

What information do patients need about medicines? "Doing prescribing": how doctors can be more effective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Electronic monitoring of medication adherence in skin disease: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Written action plans: potential for improving outcomes in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Phosphodiesterase 4-targeted treatments for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel®) for up to 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Treatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse prevention

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

21 January 2018

12 December 2020

Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8488-5

Correlation of IL-31 serum levels with severity of atopic dermatitis

21 January 2018

1 reference

12 December 2020

Topical Use of Caffeine With Hydrocortisone in the Treatment of Atopic Dermatitis

1 reference

12 December 2020

Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis

1 reference

12 December 2020

Increase in NGF content and nerve fiber sprouting in human allergic contact eczema

1 reference

12 December 2020

Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and case-control study

1 reference

12 December 2020

The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy

1 reference

12 December 2020

Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis

1 reference

12 December 2020

Topical application of emollients prevents dry skin-inducible intraepidermal nerve growth in acetone-treated mice

1 reference

12 December 2020

Isolation and lipid biochemical characterization of stratum corneum membrane complexes: implications for the cutaneous permeability barrier

1 reference

12 December 2020

Influence of chronic oestrogen treatment on the density of muscarinic cholinergic receptors and calcium channels in the rabbit uterus

1 reference

12 December 2020

Increased levels of serum IL-31 in chronic spontaneous urticaria

1 reference

12 December 2020

Effect of acupuncture on experimentally induced itch

1 reference

12 December 2020

Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.

1 reference

12 December 2020

Role of mast cells and sensory nerves in skin inflammation.

1 reference

12 December 2020

Cytokines and T cells in atopic dermatitis.

1 reference

12 December 2020

1 reference

12 December 2020

Evaluation of a new method of assessing pruritus and antipruritic drugs

1 reference

12 December 2020

Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial

1 reference

12 December 2020

Benefits of mild cleansing: synthetic surfactant based (syndet) bars for patients with atopic dermatitis

1 reference

12 December 2020

Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol

1 reference

12 December 2020

The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study

1 reference

12 December 2020

Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study

1 reference

12 December 2020

Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study

1 reference

12 December 2020

Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature

1 reference

12 December 2020

The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know

1 reference

12 December 2020

Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis

1 reference

12 December 2020

The phosphodiesterase 4 inhibitor AWD 12-281 is active in a new guinea-pig model of allergic skin inflammation predictive of human skin penetration and suppresses both Th1 and Th2 cytokines in mice

1 reference

12 December 2020

Compliance problems in paediatric atopic eczema

1 reference

12 December 2020

TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase

1 reference

12 December 2020

Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro

1 reference

12 December 2020

Physicians' perceptions of an eczema action plan for atopic dermatitis

1 reference

12 December 2020

Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation

1 reference

12 December 2020

Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants

1 reference

12 December 2020

Pathways to managing atopic dermatitis: consensus from the experts

1 reference

12 December 2020

Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).

1 reference

12 December 2020

Topical corticosteroids in dermatology

1 reference

12 December 2020

In vivo expression of IL-12 and IL-13 in atopic dermatitis

1 reference

12 December 2020

Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons.

1 reference

12 December 2020

Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis

1 reference

12 December 2020

Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression

1 reference

12 December 2020

Itch in atopic dermatitis - pathophysiology and treatment.

1 reference

12 December 2020

UVB phototherapy of atopic dermatitis

1 reference

12 December 2020

Studies of the mechanism of acute vascular reactions to injury. I. The relationship of mast cells and histamine to the production of edema by ovomucoid in rats

1 reference

12 December 2020

A cohort study on a ceramide-containing cleanser and moisturizer used for atopic dermatitis.

1 reference

12 December 2020

Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema

1 reference

12 December 2020

Patients' perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis

1 reference

12 December 2020

IL-33 induces IL-13-dependent cutaneous fibrosis

1 reference

12 December 2020

Systematic review of treatments for atopic eczema.

1 reference

12 December 2020

Gastrin-releasing peptide induces itch-related responses through mast cell degranulation in mice

1 reference

12 December 2020

IL-31 receptor alpha expression in epidermal keratinocytes is modulated by cell differentiation and interferon gamma

1 reference

12 December 2020

Long-term Safety and Efficacy of Tacrolimus Ointment for the Treatment of Atopic Dermatitis in Children

1 reference

12 December 2020

The role of selected neuropeptides in pathogenesis of atopic dermatitis

1 reference

12 December 2020

Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin.

1 reference

12 December 2020

Itch characteristics in atopic dermatitis: results of a web-based questionnaire

1 reference

12 December 2020

IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors

1 reference

12 December 2020

Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream

1 reference

12 December 2020

Do moisturizers work?

1 reference

12 December 2020

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis

1 reference

12 December 2020

Increased sensory neuropeptides in nodular prurigo: a quantitative immunohistochemical analysis

1 reference

12 December 2020

The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

The nursing programme 'Coping with itch': a promising intervention for patients with chronic pruritic skin diseases

1 reference

12 December 2020

A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle--dependent changes in mast cell--nerve fiber contacts in murine skin

1 reference

12 December 2020

Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin

1 reference

12 December 2020

Patterns of activity-dependent conduction velocity changes differentiate classes of unmyelinated mechano-insensitive afferents including cold nociceptors, in pig and in human

1 reference

12 December 2020

Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study

1 reference

12 December 2020

1 reference

12 December 2020

Specific C-receptors for itch in human skin.

1 reference

12 December 2020

Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas

1 reference

12 December 2020

Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults.

1 reference

12 December 2020

Quantitative evaluation of urea in stratum corneum of human skin

1 reference

12 December 2020

Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects

1 reference

12 December 2020

Dermatologic changes associated with interleukin 2 administration

1 reference

12 December 2020

Effect of acupuncture on experimentally induced itch

1 reference

12 December 2020

Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study

1 reference

12 December 2020

Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution

1 reference

12 December 2020

Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children

1 reference

12 December 2020

Treatment of atopic eczema with oral mycophenolate mofetil

1 reference

12 December 2020

Serum gastrin-releasing peptide levels correlate with pruritus in patients with atopic dermatitis

1 reference

12 December 2020

Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin

1 reference

12 December 2020

Treatment of therapy-resistant Sézary syndrome with Cyclosporin-A: suppression of pruritus, leukaemic T cell activation markers and tumour mass.

1 reference

12 December 2020

Receptors, cells and circuits involved in pruritus of systemic disorders

1 reference

12 December 2020

AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis

1 reference

12 December 2020

Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects

1 reference

12 December 2020

Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis.

1 reference

12 December 2020

Hydrocortisone valerate. Double-blind comparison with two other topical steroids

1 reference

12 December 2020

Matrix metalloproteinase-8 is involved in dermal nerve growth: implications for possible application to pruritus from in vitro models

1 reference

12 December 2020

Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma

1 reference

12 December 2020

Antipruritic effect of oral cyclosporin A in atopic dermatitis

1 reference

12 December 2020

Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

1 reference

12 December 2020

Scratching the surface: a role of pain-sensing TRPA1 in itch

1 reference

12 December 2020

Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors

1 reference

12 December 2020

Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters

1 reference

12 December 2020

Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects

1 reference

12 December 2020

Behavioural treatment of scratching in patients with atopic dermatitis

1 reference

12 December 2020

Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study

1 reference

12 December 2020

Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis

1 reference

12 December 2020

An attempt to clarify the influence of glycerol, propylene glycol, isopropyl myristate and a combination of propylene glycol and isopropyl myristate on human stratum corneum.

1 reference

12 December 2020

[A currently developed method of measurement. A discovery of specific nerve fibers explains the way of itching through the body]

1 reference

12 December 2020

Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis

1 reference

12 December 2020

Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice

1 reference

12 December 2020

Ceramides of pig epidermis: structure determination

1 reference

12 December 2020

Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?

1 reference

12 December 2020

Atopic dermatitis: triggering factors.

1 reference

12 December 2020

Topische Cannabinoidagonisten

1 reference

12 December 2020

A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteers

1 reference

12 December 2020

Topical TRPM8 agonist (icilin) relieved vulva pruritus originating from lichen sclerosus et atrophicus

1 reference

12 December 2020

IL-13 gene expression in patients with atopic dermatitis: relation to IgE level and to disease severity.

1 reference

12 December 2020

Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma

1 reference

12 December 2020

Outpatient care and medical treatment of children and adults with atopic eczema

1 reference

12 December 2020

Colloidal oatmeal: history, chemistry and clinical properties.

1 reference

12 December 2020

Interleukin 2 and psoriasis

1 reference

12 December 2020

10.1007/S12016-015-8488-5

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference